NO20050720L - Krystallformer av olanzapin og fremgangsmate for deres fremstilling - Google Patents
Krystallformer av olanzapin og fremgangsmate for deres fremstillingInfo
- Publication number
- NO20050720L NO20050720L NO20050720A NO20050720A NO20050720L NO 20050720 L NO20050720 L NO 20050720L NO 20050720 A NO20050720 A NO 20050720A NO 20050720 A NO20050720 A NO 20050720A NO 20050720 L NO20050720 L NO 20050720L
- Authority
- NO
- Norway
- Prior art keywords
- olanzapine
- preparation
- crystal forms
- preparing
- forms
- Prior art date
Links
- KVWDHTXUZHCGIO-UHFFFAOYSA-N olanzapine Chemical compound C1CN(C)CCN1C1=NC2=CC=CC=C2NC2=C1C=C(C)S2 KVWDHTXUZHCGIO-UHFFFAOYSA-N 0.000 title abstract 4
- 229960005017 olanzapine Drugs 0.000 title abstract 4
- 239000013078 crystal Substances 0.000 title 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 1
- 239000011877 solvent mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SI200200175A SI21270A (sl) | 2002-07-15 | 2002-07-15 | Kristalne oblike olanzapina in postopki za njihovo pripravo |
| PCT/SI2003/000024 WO2004006933A2 (fr) | 2002-07-15 | 2003-07-14 | Formes cristallines de l'olanzapine et procedes de preparation desdites formes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20050720L true NO20050720L (no) | 2005-02-10 |
Family
ID=30113490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20050720A NO20050720L (no) | 2002-07-15 | 2005-02-10 | Krystallformer av olanzapin og fremgangsmate for deres fremstilling |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7745429B2 (fr) |
| EP (1) | EP1551414B1 (fr) |
| AU (1) | AU2003256242A1 (fr) |
| CA (1) | CA2493370C (fr) |
| EA (1) | EA008055B1 (fr) |
| HR (1) | HRP20050039B1 (fr) |
| NO (1) | NO20050720L (fr) |
| PL (1) | PL217081B1 (fr) |
| RS (1) | RS53474B (fr) |
| SI (2) | SI21270A (fr) |
| UA (1) | UA83633C2 (fr) |
| WO (1) | WO2004006933A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL202856B1 (pl) * | 2002-12-20 | 2009-07-31 | Adamed Spo & Lstrok Ka Z Ogran | Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny |
| US7323459B2 (en) * | 2002-12-24 | 2008-01-29 | Teva Pharmaceutical Industries Ltd. | Crystal forms, methods for their preparation and method for preparation of olanzapine |
| ATE504588T1 (de) | 2004-01-27 | 2011-04-15 | Synthon Bv | Stabile salze von olanzapin |
| EP1720885A1 (fr) * | 2004-01-27 | 2006-11-15 | Synthon B.V. | Procede de fabrication d'olanzapine sous forme polymorphe i |
| US7906642B2 (en) * | 2004-03-08 | 2011-03-15 | Krka, Tovarna Zdravil, D.D. | Isopropanol water solvate of olanzapine |
| ES2253091B1 (es) * | 2004-07-27 | 2007-02-01 | Inke, S.A. | Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo. |
| GB0522473D0 (en) | 2005-11-03 | 2005-12-14 | Actavis Group | A pharmaceutical formulation |
| US7834176B2 (en) | 2006-01-26 | 2010-11-16 | Sandoz Ag | Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU629879A3 (ru) | 1974-11-26 | 1978-10-25 | Лилли Индастриз Лимитед, (Фирма) | Способ получени тиено(1,5) бензодиазепинов или их солей |
| US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
| EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
| US5631250A (en) * | 1995-03-24 | 1997-05-20 | Eli Lilly And Company | Process and solvate of 2-methyl-thieno-benzodiazepine |
| EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| CR5278A (es) * | 1995-03-24 | 1996-07-04 | Lilly Co Eli | Formulacion oral de 2-metil-tieno-benzodiacepina |
| US5776928A (en) * | 1995-04-21 | 1998-07-07 | Eli Lilly And Company | Method for treating dyskinesias with olanzapine |
| US6506746B2 (en) * | 1995-05-30 | 2003-01-14 | Eli Lilly And Company | Method for treating cognitive dysfunction |
| AU720366B2 (en) | 1996-09-23 | 2000-06-01 | Eli Lilly And Company | Olanzapine dihydrate D |
| ZA978515B (en) | 1996-09-23 | 1999-03-23 | Lilly Co Eli | Intermediates and process for preparing olanzapine |
| AU9583498A (en) * | 1997-09-30 | 1999-04-23 | Eli Lilly And Company | Method for treating sexual dysfunction |
| PT1246827E (pt) * | 1999-12-28 | 2005-08-31 | Cipla Ltd | Novas formas polimerficas da olanzapina |
| CA2420987A1 (fr) | 2000-08-31 | 2002-03-07 | Dr. Reddy's Laboratories Ltd. | Procede de preparation d'hydrates d'olanzapine et de conversion de ceux-ci en formes cristallines d'olanzapine |
-
2002
- 2002-07-15 SI SI200200175A patent/SI21270A/sl not_active IP Right Cessation
-
2003
- 2003-07-14 WO PCT/SI2003/000024 patent/WO2004006933A2/fr not_active Ceased
- 2003-07-14 CA CA002493370A patent/CA2493370C/fr not_active Expired - Fee Related
- 2003-07-14 EA EA200500188A patent/EA008055B1/ru not_active IP Right Cessation
- 2003-07-14 US US10/521,646 patent/US7745429B2/en not_active Expired - Fee Related
- 2003-07-14 UA UAA200501303A patent/UA83633C2/ru unknown
- 2003-07-14 AU AU2003256242A patent/AU2003256242A1/en not_active Abandoned
- 2003-07-14 EP EP03764287.3A patent/EP1551414B1/fr not_active Expired - Lifetime
- 2003-07-14 PL PL373845A patent/PL217081B1/pl unknown
- 2003-07-14 RS YU20050023A patent/RS53474B/sr unknown
- 2003-07-14 SI SI200332341T patent/SI1551414T1/sl unknown
- 2003-07-14 HR HRP20050039AA patent/HRP20050039B1/hr not_active IP Right Cessation
-
2005
- 2005-02-10 NO NO20050720A patent/NO20050720L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2493370A1 (fr) | 2004-01-22 |
| RS20050023A (sr) | 2007-06-04 |
| WO2004006933A2 (fr) | 2004-01-22 |
| EA008055B1 (ru) | 2007-02-27 |
| US7745429B2 (en) | 2010-06-29 |
| SI21270A (sl) | 2004-02-29 |
| EA200500188A1 (ru) | 2005-06-30 |
| PL373845A1 (en) | 2005-09-19 |
| HRP20050039B1 (hr) | 2014-10-10 |
| WO2004006933A3 (fr) | 2004-04-01 |
| AU2003256242A1 (en) | 2004-02-02 |
| EP1551414A2 (fr) | 2005-07-13 |
| CA2493370C (fr) | 2009-09-29 |
| US20060040920A1 (en) | 2006-02-23 |
| SI1551414T1 (sl) | 2014-04-30 |
| EP1551414B1 (fr) | 2013-11-27 |
| PL217081B1 (pl) | 2014-06-30 |
| UA83633C2 (ru) | 2008-08-11 |
| RS53474B (sr) | 2014-12-31 |
| HRP20050039A2 (en) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060402L (no) | 3-amino choman og 2-aminotetralinderivater | |
| NO20034289L (no) | N-(2-aryletyl)benzylaminer som antagonister av 5-HT6- reseptoren | |
| NO20044221L (no) | Nye forbindelser | |
| NO20082330L (no) | Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav | |
| EA200701358A1 (ru) | Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина | |
| MXPA02012795A (es) | Carvedilol. | |
| ECSP045088A (es) | Forma polimorfica de rimonabant, su procedimiento de preparacion y composiciones farmaceuticas que la contienen | |
| WO2005069784A3 (fr) | Point d'acces public | |
| NO20052591D0 (no) | Pyridopyrolizin og pyridoindolizinderivater | |
| ATE393764T1 (de) | Polymorphe formen von valsartan | |
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| NO20043842L (no) | Nye krystallformer av atorvastatinhemikalsium og fremgangsmater for fremstilling derav, savel som nye fremgangsmater for fremstilling av atorvastatinhemikalsiumform I, VIII og IX | |
| NO20054876D0 (no) | Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser | |
| NO20062021L (no) | Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika | |
| EA200600485A1 (ru) | Способ получения производных 2-оксо-1-пирролидина | |
| DK0981525T3 (da) | (2-(2-Thienyl)-ethylamino)-(2-halophenyl)-acetonitriler som mellemprodukter og fremgangsmåde til deres fremstilling | |
| WO2005060693A3 (fr) | Utilisation de composes a base de 9-desoxoerythromycine comme agents procinetiques | |
| NO20024321L (no) | Fremgangsmate for fremstilling av krystallinsk form I av kabergolin | |
| DK1383742T3 (da) | Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater | |
| NO20070550L (no) | Fremgangsmate for fremstilling av pyrrolotriazinforbindelser | |
| DK1673354T3 (da) | Arylindenopyridiner og arylindenopyrimidiner og deres anvendelse som adenosin-A2a-receptorantagonister | |
| NO20053473D0 (no) | Fremgangsmate for fremstilling av R,R (eller S,S) konfigurasjonen av glykopyrroniumstereoisomerer | |
| HRP20050039B1 (hr) | Kristalne forme olanzapina i postupci njihove priprave | |
| NO20050885L (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre |